Tag: Ketorolac Tromethamine

Alembic Pharmaceuticals gets FDA final approval for Ketorolac Tromethamine

Alembic Pharmaceuticals has secured final approval for its abbreviated new drug application (ANDA) for Ketorolac Tromethamine Injection USP, 15 mg/mL, 30 mg/mL, and 60 mg/2 ... Read More